Our recent data demonstrate that inhibition of SATB2 expression by Crisp/Cas9 technique suppresses epithelial–mesenchymal transition, stem cell markers and pluripotency maintaining factors in CSCs derived from HCC.13 The gene discussed is SATB2; the disease is hepatocellular carcinoma.